Sanofi Genzyme Competitors and Similar CompaniesClear all
Sanofi Genzyme's competitors and similar companies include Biogen and Amicus Therapeutics.
 Sanofi Genzyme Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. |  Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. | |
Founding Date | Founding Date 1981 | Founding Date 1978 | Founding Date 2002 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Cambridge, US HQ Macquarie Park, AU Malaga, AU Virginia, AU São Paulo, BR Mississauga, CA Toronto, CA see more | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more |
Employees | Employees 9,9041% decrease | Employees 7,605 | Employees 58415% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 26.7 b | Valuation ($) 3.4 b |
Financial | |||
Revenue (est.) | Revenue (est.) €10.4b (FY, 2019) | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) $634.2m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $2.4b (FY, 2025) | Cost of goods $72.9m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $7.5b (FY, 2025) | Gross profit $561.3m (FY, 2025) |
Net income | Net income N/A | Net income $1.3b (FY, 2025) | Net income ($27.1m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View companyAmicus Therapeutics
HQ
Philadelphia, US
Employees
584↑ 15% increase
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View company